On January 26, Dr. Michael Bohan, who serves on our medical advisory board, operated our booth at the Medicating Normal Screening. Medicating Normal is an award-winning documentary telling the untold story of the potential long-term…
The second paper reporting data from the benzodiazepine experience survey is now available online. The survey was designed in 2018 by Dr. Jane Macoubrie, a professor of communications and member of BIC’s general advisory board,…
Our Latest Updates Our medical director, Dr. Huff, presented the pilot training course Recovering from Benzodiazepines for Peer Support with D Foster of Easing Anxiety and Ginger Ross of Choices Recovery Training. This course, developed by the…
Question: “How can I best support my adult child through benzodiazepine withdrawal?” Answer: First of all, thank you for offering your support—I can personally attest to how important it is to have family in one’s…
BIC Updates We welcome Denise Senyk, M.D. to our medical advisory board. Our Outreach Interesting Research Benzo Updates Benzo-related Media
We received a new FDA communication dated August 3, 2022 about benzodiazepine use during pregnancy: This communication is to inform you that FDA is requiring manufacturers of all benzodiazepine medicines to update and standardize the…
Our director is presented her lived benzodiazepine experience as a keynote speaker for the California Society of Addiction Medicine’s 2022 conference, August 24 through the 27th. The California Society of Addiction Medicine is the largest…
The last several months have been busy for our volunteers, with recent work focused on improving benzodiazepine awareness in the medical field. Our message to the medical field is that they are failing prescribed benzodiazepine patients. We…
